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Abstract 
Background: Myanmar commenced a lymphatic filariasis (LF) elimination programme in 2000. Whilst the country 
has made considerable progress since then, a number of districts have demonstrated persistent transmission after 
many rounds of mass drug administration (MDA). The causes of unsuccessful MDA have been examined elsewhere; 
however, there remains little information on the factors that contribute in Myanmar.
Methods: We conducted an analysis of factors associated with persistent infection, LF-related hydrocoele and MDA 
participation in an area with ongoing transmission in 2015. A cross-sectional household survey was undertaken 
in 24 villages across four townships of Mandalay Region. Participants were screened for circulating filarial antigen 
(CFA) using immunochromatographic tests and, if positive, for microfilaria by night-time thick blood slide. Individu-
als 15 year and older were assessed for filariasis morbidity (lymphoedema and, if male, hydrocoele) by ultrasound-
assisted clinical examination. A pre-coded questionnaire was used to assess risk factors for LF and for non-participa-
tion (never taking MDA). Significant variables identified in univariate analyses were included in separate step-wise 
multivariate logistic regressions for each outcome.
Results: After adjustment for covariates and survey design, being CFA positive was significantly associated with age 
[odds ratio (OR) 1.03, 95% CI 1.01–1.06), per year], male gender (OR 3.14, 1.27–7.76), elevation (OR 0.96, 0.94–0.99, per 
metre) and the density of people per household room (OR 1.59, 1.31–1.92). LF-related hydrocoele was associated 
with age (OR 1.06, 1.03–1.09, per year) and residing in Amarapura Township (OR 8.93, 1.37–58.32). Never taking MDA 
was associated with male gender [OR 6.89 (2.13–22.28)] and age, particularly in females, with a significant interaction 
term. Overall, compared to those aged 30–44 years, the proportion never taking MDA was higher in all age groups 
(OR highest in those < 5 years and > 60 years, ranging from 3.37 to 12.82). Never taking MDA was also associated 
with residing in Amarapura township (OR 2.48, 1.15–5.31), moving to one’s current village from another (OR 2.62, 
1.12–6.11) and ever having declined medication (OR 11.82, 4.25–32.91). Decreased likelihood of never taking MDA 
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Background
Lymphatic filariasis (LF) remains a major cause of perma-
nent disability in tropical and sub-tropical countries [1]. 
Chronic infection with filarial worms causes lymphatic 
dysfunction leading to the progressive and irreversible 
swelling of the limbs and genitals. This results in substan-
tial disability, discomfort, social stigma and economic 
disadvantage.
In response, the World Health Organisation (WHO) 
established the Global Programme to Eliminate LF in 
2000, which is based on two intervention pillars. The first 
is to interrupt the transmission of LF through mass drug 
administration (MDA) of an annual dose of anti-filarial 
medications to at-risk populations [1]. The medica-
tions include albendazole plus either diethylcarbamazine 
(DEC) or ivermectin and are administered for a mini-
mum of 5 consecutive years. The second component is 
to alleviate the suffering of those with existing LF-related 
disease through targeted management programmes.
Worldwide, the WHO South-East Asian Region has the 
highest burden of LF [1, 2]. Myanmar (formerly Burma) 
is one of the most affected countries in this region, with 
41 million people (80% of the population) at risk [3, 4]. 
Filariasis in the country is distributed predominantly in 
the central and western dry zones, where baseline (pre-
MDA) prevalence was 20 to 30% [3–6]. The parasite 
Wuchereria bancrofti is the sole reported cause of LF 
in the country where it is transmitted by the mosquito 
Culex quinquefasciatus [4, 7].
Myanmar commenced an MDA programme with DEC 
and albendazole in 2001. Since then, the country has 
made considerable progress toward the elimination of LF, 
but has also faced a number of challenges [3–5]. Medica-
tion supply and financial issues, as well as concerns over 
the reported incidence of serious adverse reactions, led to 
the interruption of a number of MDA rounds at both the 
national and regional levels [3, 8]. Whilst treatment cov-
erage across the country has reportedly been high (60.0% 
to 100%), actual participation may have been much lower 
in some areas [3, 5, 9, 10].
Mass drug administration rounds have led to con-
siderable reductions in LF prevalence in many areas of 
Myanmar [3–5]. A number of districts, however, have 
demonstrated persistent transmission despite many 
rounds of MDA, suggesting that the programme there 
had not been fully successful [3–5, 9, 10]. A number of 
reasons have been shown to account for the failure of 
MDA rounds to interrupt transmission in other coun-
tries [11, 12]. These include programmatic factors (the 
delivery and distribution of medication to eligible par-
ticipants) or those relating to individual compliance (eli-
gible participants taking the offered medication). Whilst 
there are common trends, the combination of factors that 
undermines success varies from region to region. Deter-
mining the causes of persistent transmission specific to 
Myanmar is crucial to ensuring effective elimination 
efforts.
Recently, an independent survey was conducted in 
four townships of Mandalay Region that had demon-
strated ongoing transmission [9]. It found that 20% of the 
population had not participated in any of the six rounds 
of MDA. Of those who had, medication had only been 
taken on average 2.73 times. While this study provided an 
accurate estimate of LF burden and MDA participation, 
there remains no data on the potential causes of ongo-
ing transmission or low medication uptake in Myanmar. 
We therefore conducted an analysis to determine the 
factors associated with persistent infection and non-par-
ticipation (never taking MDA) in the country. Never tak-
ing MDA could be due to a number of factors, including 
lack of access (the programme did not reach the person 
to offer it), absence during MDA rounds, ineligibility due 




Myanmar is a lower-middle-income country in Southeast 
Asia which had a population of 51  million at the 2014 
census [13]. The country is administratively divided into 
a union territory (Naypyitaw), seven states and seven 
regions. These 15 administrative areas are further divided 
into districts, townships, cities, towns, wards, village 
tracts and villages.
Mandalay Region is situated in the low-lying and dry 
central plains of Myanmar. The majority of its popula-
tion (6 million in 2014) live rurally in villages, where the 
was associated with a higher proportion of household members being present during the last MDA round (OR 0.16, 
0.03–0.74) and the number visits by the MDA programme (OR 0.69, 0.48–1.00).
Conclusions: These results contribute to the understanding of LF and MDA participation-related risk factors and will 
assist Myanmar to improve its elimination and morbidity management programmes.
Keywords: Lymphatic filariasis, Risk factors, Myanmar, Asia, Infection, Hydrocoele, Mass drug administration, 
Coverage, Compliance, Participation
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predominant occupation is farming [13]. The region’s 
capital, Mandalay, is the second largest city in Myanmar 
[13].
The study area included four of townships in the 
Mandalay Region (Amarapura, Patheingyi, Tada-U and 
Wundwin) where the prevalence of LF had been histor-
ically high [3, 14]. Patheingyi and Amarapura lie on the 
outskirts of Mandalay City, whilst Tada-U and Wund-
win are located more rurally to the south. Amarapura, 
Patheingyi and parts of Tada-U Township lie close 
to the Irrawaddy River and its tributaries, whilst the 
Samon River passes through Wundwin. Amarapura 
also lies adjacent to the large Taung Tha Man Lake. A 
map of the study area is presented in Dickson et al. [9].
Study design
A cross-sectional household survey was conducted 
between February and March 2015 to assess the preva-
lence of LF infection and disease, participation in the 
MDA programme and risk factors for LF and never tak-
ing MDA. The study methodology has been reported 
previously alongside the results for LF prevalence and 
MDA participation [9].
In brief, a two-stage random cluster sampling method 
was used to select households from 24 villages across 
the four townships. Consenting household members 
were screened for LF infection, examined for LF-related 
morbidity and completed a risk-factor questionnaire.
Infection screening: Individuals 1  year and older 
were tested for circulating filarial antigen (CFA) 
(signifying current infection) using Binax Now Fila-
riasis Immunochromatographic test (ICT) cards 
(Alere Inc, MA, USA) on finger-prick blood sam-
ples. Individuals who were antigen positive had a 
further 60  μl of finger-prick blood taken between 
2200 and 0200 and applied to duplicate microscope 
slides using the three-line technique to assess for 
microfilaraemia (Mf ).
Clinical examination: Under the supervision of 
medical doctors, trained health workers exam-
ined participants aged 15  years and older for the 
presence of acute and chronic filariasis-related 
morbidity. Suspected cases of hydrocoele were 
confirmed using ultrasound (Sonosite M-Turbo, 
Bothwell, WA, USA).
Risk factor questionnaire and GPS mapping: A pre-
coded questionnaire was used to assess participation 
in the MDA programme as well as factors associated 
with LF infection, disease and never taking MDA. 
Prior to data collection, the questionnaire was trans-
lated into the Myanmar language (Burmese) and pre-
tested with staff of the Vector Borne Disease Control 
Unit. Trained health workers completed a brief ques-
tionnaire with each participant (Additional file  1) 
followed by a more detailed questionnaire with the 
household head (Additional file  2). Direct observa-
tion was used to verify respondent answers where 
possible. A global positioning device was used to 
record the location and elevation of each household.
Data analysis
Independent variables: Data were collected on paper 
forms in the Myanmar language (Burmese) and entered 
into Excel format before transfer to STATA. The distance 
between households and large bodies of water was cal-
culated in ArcMap 10.5 (ESRI, Redlands, CA). An elec-
tronic map of inland water bodies in shapefile format 
was obtained from Global Administrative Areas database 
(http://www.gadm.org/count ry). The distance between 
households and water bodies was then calculated using 
the Near function of the Proximity Tool. The shortest 
distance was determined using the planar (flat earth) 
method. An LF knowledge score was created from survey 
questions to assess the relationship between knowledge 
of LF and MDA participation. Participants received a 
point each if they had heard of LF and then if they cor-
rectly identified LF’s mode of transmission, symptoms 
and treatment, giving a maximum possible score of four 
points.
Univariate analyses: Statistical analysis was completed 
using STATA version 14.2 (StataCorp, Colleg Station, 
TX, USA). First, a series of univariate analyses were com-
pleted to assess the association between potential risk 
factors for each of the three outcomes: infection (CFA 
positive), LF related-hydrocoele and never taking MDA 
medication. A risk factor analysis for lymphoedema 
could not be undertaken as no cases were identified in 
the sample. Microfilaria positivity was not included as 
an outcome variable because there were a small number 
of Mf positive individuals and the results were collinear 
with CFA positivity.
The ‘svy’ prefix command was used to adjust for clus-
tering effect and weight for sampling probability. T-tests, 
χ2 and logistic regression were used to compare variables 
and generate odds ratios adjusted for survey design. Inde-
pendent variables with a p-value < 0.2 were included in 
the multivariate analysis. Circulating filarial antigen posi-
tivity and hydrocoele demonstrated a linear association 
with age, so age by year was used. In contrast, the associa-
tion between never taking MDA and age had a bimodal 
distribution, so age by quintile was used. Total household 
income data demonstrated a skewed distribution, so the 
log of income was used to normalise its distribution.
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Multivariate analyses: Next, separate backward mul-
tivariate logistic regression analyses were completed for 
each of the three outcomes with adjustment for survey 
design. The variable ‘Township’ was added at the end 
of the analyses to assess whether there were additional 
unmeasured fixed effects associated with township that 
had not been accounted for. Risk factors with a p-value 
< 0.05 were considered significant. Participants with 
incomplete data were excluded from analyses.
Results
Characteristics of the study population
A total of 450 households in 24 villages were sampled. 
Of those, 20 households (4.4%) were excluded: 15 were 
absent and 5 declined to participate. From the remain-
ing 430 households, 1014 individuals participated in the 
study. The median age of participants was 36 years [inter-
quartile range (IQR): 30, range: 1–86]. Significantly more 
females than males were included in the sample (63.7% 
vs 36.3%, p < 0.001) with no significant difference in age 
between genders. The median number of inhabitants per 
household was four (IQR: 3, range: 1–12) with an average 
household monthly income of 120,000 Myanmar kyat (85 
USD) (IQR: 120,000, range: 5,000 to 1,500,000).
LF infection prevalence
Forty-six of the 1001 participants tested for infection 
by CFA were positive (crude prevalence: 4.6%, adjusted 
for age, gender and survey design: 2.63%). The median 
age of infected individuals was 46 years (IQR: 23, range 
8–81 years). A cluster of five villages in Amarapura and 
Tada-U townships had a notably higher prevalence of 
infection compared to the remaining villages (mean 
13.32% vs 1.14%). Microfilariae were found in 39.02% 
of antigen positive individuals, representing an overall 
adjusted Mf prevalence estimate of 1.03% (assuming all 
antigen negative persons were also Mf negative).
Hydrocoele prevalence
Fifteen of the 269 men aged over 15 years who were 
examined had an LF-related hydrocoele (crude preva-
lence 5.58%, adjusted for age and survey design 2.78%). 
The median age of males suffering from an LF-related 
hydrocoele was 55  years (IQR: 12, range: 48–71  years). 
The highest prevalence occurred in three villages in 
Amarapura Township where adjusted prevalence ranged 
from 21.53 to 36.81%.
MDA programme participation
Ninety-five per cent of households reported ever being 
visited by the MDA programme. Of these, the mean 
number of visits was 2.59. Ninety per cent of household 
members reported being present during the last MDA 
round in 2014. Eighty per cent of participants reported 
taking MDA medication at least once—in other words, 
20% were systematic non-takers who had never taken 
MDA. Of those who had ever taken MDA, the mean 
number of times medication had been consumed was 
2.73. Ten per cent of participants had actively declined 
to take MDA medication (despite it being offered) on at 
least one occasion. The most common reasons reported 
were a fear of side effects and a perception that co-mor-
bidities were a contraindication.
Risk factors for LF infection
Table  1 outlines the univariate analysis of factors asso-
ciated with LF infection (by CFA) adjusted for sur-
vey design (i.e. weighted for sampling probability and 
adjusted for clustering). Infection was positively associ-
ated with age (by year), male gender, household monthly 
income, residing in Amarapura township, the absence 
of screens/glass on household windows, the number of 
people per household room and having moved to one’s 
current village. Infection was also positively associated 
with never taking MDA medication as well as not taking 
it in the last year. Infection was negatively associated with 
elevation (per metre) and distance to the nearest body of 
water (per km).
Table  2 demonstrates the factors significantly associ-
ated with LF infection following adjusted multivariate 
logistic regression. Forty-nine of the 1001 participants 
tested for infection were excluded from the final multi-
variate model due to missing data. Infection was posi-
tively associated with age (per year), male gender and 
the number of people per household room. Infection was 
negatively associated with elevation (per metre).
Risk factors for LF‑related hydrocoele
Table  3 shows the univariate association between LF-
related hydrocoele and potential risk factors. Hydrocoele 
was positively associated with age (by year) and resid-
ing in Amarapura Township and negatively associated 
with working in an outdoor environment. A relation-
ship between hydrocoele, frequency of bathing and shoe 
wearing was hypothesised; however, there was insuffi-
cient variance in responses to assess the association.
Table  4 summarises the significant factors associated 
with LF-related hydrocoele following multivariate logistic 
regression. All but 1 of the 269 men examined for hydro-
coele were included in the multivariate model. Hydro-
coele was positively associated with age (by year) and 
residing in Amarapura Township.
Risk factors for never taking MDA medication
Table 5 shows the univariate analysis of potential factors 
associated with never taking MDA medication, adjusted 
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for survey design. Never taking MDA was positively asso-
ciated with male gender, moving to one’s current village, 
declining offered MDA medication, residing in Amara-
pura and Tada-U Townships and the number of people 
per household room. Never taking medication was nega-
tively associated with knowledge of LF, being visited by 
the MDA programme and the number of times visited. 
Since never taking MDA occurred more often in those 
who declined medication and had a lower knowledge of 
LF, a side analysis of the relationship between these two 
independent variables was conducted. Declining offered 
medication was significantly less likely in those with 
greater LF knowledge (OR = 0.68, p = 0.025).
Table  6 illustrates the factors significantly associated 
with never taking MDA following multivariate analysis, 
with adjustment for survey design. Of the 1007 partici-
pants who self-reported MDA participation, 163 were 
excluded from the final multivariate model as a result 
of missing data. Never taking MDA was positively asso-
ciated with extremes of age (< 15 years and ≥ 60 years), 
male gender, moving to one’s current village of residence, 
ever declining MDA medication and residing in Amara-
pura Township. It was negatively associated with the 
number of visits by the MDA programme and the pro-
portion of household members present during the last 
MDA.
The proportion of those who had never taken MDA by 
age varied between genders (Additional file 3: Figure S1). 
To assess the influence of gender on age, an interaction 
term was added to the multivariate analysis (Table  6). 
The analysis indicated that there was significant interac-
tion between age and gender, with the effect of age much 
more apparent in females. Females aged 30 to 44  years 
are most likely to have taken medication, whilst males 
of all ages and females < 30 years or > 44 years old were 
more likely to have never taken MDA.
Discussion
This study has been the first to examine risk factors 
related to LF and MDA participation in Myanmar. It 
assessed three outcomes in an area with ongoing trans-
mission after six rounds of MDA including: persistent 
infection (measured by CFA), never taking MDA medica-
tion and LF-related hydrocoele. It found that persistent 
infection was related to both individual demographics 
(age and gender) and household factors (altitude and 
density of persons per room). Never taking MDA medi-
cation was associated with both programme reach and 
individual compliance factors. Finally, LF-related hydro-
coele was significantly associated with increasing age 
and residing in the historically endemic township of 
Amarapura.
Despite six rounds of MDA, infection remained sig-
nificantly associated with baseline risk factors, which 
include host characteristics and exposure to infected 
vectors. The relationship between infection and 
increasing age found in this study is well established 
[15]. It is thought to relate to both increasing expo-
sure to infected mosquitoes with age and the inefficient 
transmission of L3 larval stages from mosquitoes to 
humans [16].
The higher prevalence of LF infection amongst males 
found here is also well documented [15, 17]. Histori-
cally, it was suggested that this was the result of greater 
occupational exposure. However, the persistence of 
male predominance, following adjustment for occu-
pation, outdoor work and MDA participation in this 
analysis, supports the hypothesis that there is also a 
biological basis for this difference [18–20].
Risk of infection was strongly associated with the 
number of people per household room, a marker of 
crowding. Entomological studies have shown that 
rooms with more inhabitants have an increased density 
of indoor Culex mosquitoes [21]. It is therefore hypoth-
esised that crowding may lead to greater density of 
indoor Culex mosquitoes increasing transmission risk 
amongst household members. Efforts to reduce over-
crowding, which are employed for other communicable 
diseases, may therefore also decrease LF transmission. 
Whilst a relationship between crowding and infection 
has not previously been documented, a link has been 
observed between household size and infection in 
children in Brazil, where Culex is also the vector [22]. 
When crowding was replaced by household size in our 
final model, there was a positive association, but it did 
not reach significance (p = 0.058, results not shown). 
This suggests that household size, as well as density, 
may predispose to infection in Culex regions, but this 
requires further investigation.
The absence of screens or glass on household windows 
was also associated with higher infection risk but lost 
significance in the multivariate analysis following adjust-
ment for survey design. This may be due to sample heter-
ogeneity, and that Amarapura Township had both a high 
infection prevalence and low number of screens/glass 
on windows. The relationship is nonetheless notewor-
thy, because studies in Africa have shown that windows 
and doors are the preferred entry point for Culex mos-
quitoes, and the addition of screens reduces their indoor 
density [23, 24]. Other variables related to night-time 
vector exposure, including bednet ownership and usage, 
also showed a protective association, but did not reach 
significance. This was probably because bednet owner-
ship and usage were uniformly high across the study area. 
Although these associations did not reach significance 
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Table 1 Univariate logistic regression analysis of association between infection (measured by  CFAa) and individual/household risk 
factors; weighted and adjusted for survey design (n = 1001)
Risk factor Total (n) CFA positive (%)b CFA positive
aORb 95%  CIc P
Individual risk factors
 Age (per year) 997 – 1.03 1.01–1.05 0.011
 Gender 1001
  Male 365 4.76 2.34 1.03–5.36 0.044
  Female 636 2.09
 Occupation 975
  None/home duties 257 2.84 1.01 0.27–3.82 0.985
  Student 160 0.78 0.27 0.02–3.20 0.286
  Manual labour 519 4.00 1.45 0.35–5.97 0.596
  Other (ref ) 39 2.80
 Work environment 947
  Outdoor 325 3.26 1.08 0.47–2.47 0.853
  Indoor or mixed 622 3.03
 Moved to current village 992
  Yes 148 8.13 3.46 1.45–8.25 0.007
  No 844 2.49
 Slept under a bednet last night 996
  Yes 907 2.75 0.46 0.10–2.07 0.298
  No 89 5.76
 Never taken MDA medication 994
  Yes 188 7.55 3.67 1.51–8.93 0.006
  No 806 2.18
 No. times MDA taken 985 – 0.78 0.57–1.08 0.133
  0 (ref ) 188 7.55
  1–2 336 2.92 0.37 0.12–1.16 0.085
  3–4 273 0.57 0.07 0.01–0.37 0.003
  5–6 188 4.40 0.56 0.20–1.62 0.273
 Did not take MDA last year 994
  Yes 237 7.18 3.80 1.57–9.17 0.005
  No 757 2.00
Household risk factors
 Township 1001
  Amarapura 297 9.07 9.96 2.98–33.29 0.001
  Patheingyi 113 2.61 2.68 0.24–29.54 0.405
  Tada-U 267 3.38 3.49 0.87–13.94 0.075
  Wundwin (ref ) 324 0.99
 Log household monthly income 965 – 1.89 1.30–2.75 0.002
 Highest level of education 993
  None/primary 325 3.38 7.44 0.82–67.34 0.072
  Secondary 528 3.81 8.43 0.95–74.90 0.055
  Tertiary (ref ) 140 0.47 1.00
 Elevation (by metre) 997 – 0.95 0.92–0.99 0.011
 Distance to nearest water body (per km) 989 – 0.91 0.85–0.98 0.011
 No screens or glass on windows 994
  Yes 373 6.43 3.52 1.32–9.44 0.015
  No 621 1.92
 No. people in household 997 – 1.24 0.96–1.60 0.092
 No. people per bednet (ratio) 987 – 1.23 0.99–1.53 0.065
 No. of people per room (ratio) 965 – 1.60 1.35–1.89 < 0.001
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in the final model, together they indicate that individu-
als may be infected whilst in their household but outside 
of their bednet. The addition of screens to household 
windows could therefore be an effective intervention to 
reduce LF transmission and deserves further study and 
trials.
An interesting finding was the association between 
small changes in elevation and infection risk. Whilst a 
negative association between elevation and infection 
risk is well documented, this typically occurs with larger 
variations in altitude [25, 26]. This is because at higher 
altitudes, atmospheric temperatures decrease, result-
ing in reduced mosquito survival and slower parasite 
development within the vector [27]. In this area, which 
is located within the central plains of Myanmar, altitude 
only ranged between 45 and 269 m above sea level. This 
would be insufficient to affect vector survival, but instead 
indicates low-lying households that may be closer to bod-
ies of water. The distance from households to large bodies 
of water was also directly measured. Whilst significant 
in the univariate analysis, the variable lost significance 
when it replaced or was added alongside elevation in the 
final model. This could be because elevation more accu-
rately captured subtle proximity to water such as smaller 
waterways, areas prone to flooding or households closest 
to water along a riverbank. These findings support ear-
lier work in demonstrating the usefulness of elevation as 
an indirect marker for proximity to water and therefore 
infection risk in low-lying contexts [28].
A suggestive finding in this study was the association 
between persistent infection and never taking MDA. 
Whilst the relationship lost significance after adjustment 
for survey design in the multivariate analysis, possibly 
due to the clustering of those who had never taken MDA, 
it retained a strong positive effect (OR = 2.15). This rela-
tionship may be explained by both the mechanisms with 
which MDA medications control LF at the individual and 
community levels. The predominant effect of MDA is 
microfilaricidal, thereby reducing local transmission and 
the chance of new infection [29]. This is reflected in the 
study area, where villages with > 65% MDA participation 
had a mean CFA prevalence of 2.08% compared to 9.76% 
in villages with less participation. The secondary effect is 
macrofilaricidal, reducing the burden of adult worms and 
therefore eventually CFA [30]. At the individual level, 
this likely explains the lower weighted and adjusted prev-
alence in those who had participated in the MDA pro-
gramme (1.60%) compared to those who had not (6.74%). 
The high prevalence of infection amongst ‘systematic 
non-takers’ supports studies elsewhere in highlighting 
their significant role as a reservoir for ongoing transmis-
sion in the community [31, 32].
Compared to the logical relationship between infec-
tion and never taking MDA medication, the association 
with the number of times MDA was taken was complex 
and non-intuitive. Relative to those who have never taken 
MDA, infection prevalence progressively reduced in 
those who took MDA a few or intermediate number of 
times, but then increased in those who took MDA five or 
six times (Table 1). All of the participants with infection 
who reported taking five to six rounds of MDA resided in 
Amarapura, the highest prevalence township (Additional 
file  4: Figure S2). These individuals may therefore have 
been more intensively targeted, at greater risk of re-infec-
tion or more familiar with MDA and thus more likely to 
give responses showing social desirability bias. Of note, 
the accuracy of self-reported MDA participation has not 
been validated beyond 1  year, so may also be prone to 
significant recall bias.
Understanding the causes of never taking MDA 
medication (i.e systematic non-participation) are cru-
cial to improving control efforts, that is, distinguishing 
between programmatic deficiencies (not reaching house-
holds or visiting at inconvenient times) from individual 
reasons (such as refusal or perceived ineligibility). In 
the study area, never taking MDA was related to both 
Table 1 (continued)
a Circulating filarial antigen
b Adjusted for survey design
c 95% confidence interval
Italics values indicate P < 0.05
Table 2 Multivariate logistic regression analysis of association 
between infection (measured by  CFAa) and individual/household 
risk factors; weight and adjusted for survey design (n = 952)
a Circulating filarial antigen
b Adjusted for survey design
c 95% confidence interval
Italics values indicate P < 0.05
Risk factor aORb 95%  CIc P
Individual risk factors
 Age (per year) 1.03 1.01–1.06 0.003
 Male gender 3.14 1.27–7.76 0.015
 Never taken MDA medication 2.15 0.73–6.32 0.154
Household risk factors
 Elevation (m) 0.96 0.94–0.99 0.019
 No. of people per room (ratio) 1.59 1.31–1.92 < 0.001
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Table 3 Univariate logistic regression analysis of association between LF-related hydrocoele and individual/household risk factors; 
weighted and adjusted for survey design (n = 269)
a Adjusted for survey design
b 95% confidence interval
c Unadjusted values given due to study stratum with single sampling unit
d Circulating filarial antigen
e All CFA negative individuals assumed to be microfilariae negative
Italics values indicate P < 0.05
Risk factor Total Proportion with 
hydrocoele (%)a
Hydrocoele present
aORa 95%  CIb P
Individual risk factors
 Age (by year) 268 – 1.05 1.03–1.08 < 0.001
 Occupation 265
  None/home duties 32 10.45 1.85 0.17–2.82 0.603
  Student 2 0 –
  Manual labour 213 3.32 0.54 0.04–6.89 0.625
  Other (ref ) 18 5.93 1.00
 Work environment 258
  Outdoor 145 0.85 0.20c 0.05–0.72 0.014
  Indoor or mixed 113 7.29
 Moved to current village of residence 268
  Yes 42 7.68 2.14 0.45–10.24 0.327
  No 226 3.75
 CFAd positive 269
  Yes 19 12.25 3.65 0.81–16.38 0.088
  No 250 3.69
 Microfilariae  positivee 266
  Yes 7 18.18 5.39 0.83–35.04 0.076
  No 259 3.96
 Never taken MDA medication 269
  Yes 56 4.66 1.15 0.22–5.98 0.859
  No 213 4.07
Household risk factors
 Township 269
  Amarapura 59 13.92 11.12 1.85–66.89 0.011
  Patheingyi 27 8.02 5.98 0.40–89.48 0.184
  Tada-U 64 1.73 1.21 0.08–17.21 0.884
  Wundwin (ref ) 119 1.44 1.00
 Log household monthly income 1.43 0.77–2.64 0.241
 Highest HH education 268
  None/primary 81 2.74 0.26 0.03–2.78 0.253
  Secondary 150 3.29 0.32 0.04–2.41 0.253
  Tertiary (ref ) 37 9.72 1.00
 Drinking water type (by WHO classification) 268 – 1.01 0.41–2.47 0.981
 Sanitation type (by WHO classification) 269 – 0.26 0.04–1.63 0.143
 Elevation (by metre) 269 – 0.98 0.96–1.01 0.148
 Distance to nearest water body (per km) 267 – 0.95 0.89–1.01 0.075
 No. of people per HH room (ratio) 259 – 1.35 0.92–1.98 0.116
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programmatic reach (the proportion of targeted persons 
who are offered medication) and individual compliance 
(the proportion who take the offered medication).
The programmatic factors associated with never tak-
ing MDA suggested households were either not visited by 
the programme or the members of the household were 
absent at the time of the visit. While almost all (95%) sur-
veyed households reported being visited by an MDA pro-
gramme member at least once, the mean number of visits 
was only 2.59, with fewer visits predictive of never taking 
MDA. In the households that were visited, absenteeism 
further predisposed to never taking medication. Never 
taking MDA was less likely in persons from households 
with more members present during the last round.
The association between never taking MDA, age and 
gender may also relate to absenteeism. Males of all ages 
and females outside of the 30 to 44 year age group were 
more likely to have never taken MDA. In Mandalay 
Region, women are more likely than men to be household 
workers, with the greatest proportion of these women 
aged between 25 and 49 years [33]. This suggests that the 
programme may have more successfully reached these 
women because they were at home during the day com-
pared to the others who were more likely to be absent.
The greater likelihood of never taking MDA in persons 
that had migrated from another village may also relate 
to programme reach. This finding was somewhat unex-
pected as we had no prior knowledge of the frequency, 
extent or origin of population movement. Domestic 
migration could be a cause of never taking medication for 
a variety of reasons, such as moving from non-endemic 
areas, missing rounds due to travel or non-registration 
at the current residence. A limitation of our study was 
that we did not ascertain the source of migration, which 
is likely to include both long-range migration from areas 
up-river as well as local movement between villages. 
Information on migration including its source and fre-
quency should be further investigated in future studies 
together with information on length of residence in their 
village.
These findings corroborate those of Linn et  al. who 
recently conducted a qualitative survey on barriers to 
MDA participation in Myanmar (unpublished) [34]. They 
interviewed members of the community and National 
Program to Eliminate LF (NPELF) in three townships 
with persistent transmission in Mandalay and the adja-
cent Magway and Sagaing Regions. They found commu-
nity members were often unaware of previous rounds, 
suggesting they may have been missed. Of those who 
were aware of the previous rounds, a number stated they 
had not received medication because they were away. 
Meanwhile, drug distributors reported that financial, 
human resource and time limitations prevented them 
from fulfilling their duties and mopping-up recipients 
who were initially missed. The NPELF should therefore 
ensure that future rounds reach all households, are suf-
ficiently resourced and are conducted at a time when 
household members are likely to be present. A strong 
emphasis should also be made to track down eligible 
recipients who were missed during the initial round.
In addition to programmatic reach, never taking MDA 
was also at least partly related to individual compliance in 
the study area. A notable proportion of the participants 
(8% of 935) reported that they had refused MDA at least 
once in the past. Of those, 52% had never taken MDA 
compared to only 11% among participants who had never 
actively refused medication. Thus, ever declining medi-
cation was strongly associated with never taking MDA. 
The most common reasons for declining MDA reported 
in both our study and that of Linn et  al. were fear of 
side effects and a perception that co-morbidities were a 
contraindication [34]. Although adverse events are rare, 
community concern has hampered MDA in many coun-
tries and resulted in the postponement of the 2006 MDA 
round in the Mandalay Region [3].
Education initiatives regarding LF, the MDA pro-
gramme and common misconceptions have been effec-
tive in improving MDA compliance [35–37]. These 
studies reported that greater LF knowledge reduced the 
likelihood of declining medication and non-participation, 
suggesting that these interventions would likely also be 
effective in Myanmar. The NPELF should consider efforts 
to improve community education and dispel myths to 
improve MDA participation.
Amarapura had significantly more individuals who had 
never taken MDA compared to the other townships in the 
study. Douglass et al. similarly found low participation in 
young people surveyed there in 2013 and 2014 [10]. This 
Table 4 Multivariate logistic regression analysis of association 
between LF-related hydrocoele and individual/household risk 
factors; adjusted for survey design (n = 268)
a Adjusted for survey design
b 95% confidence interval
Italics values indicate P < 0.05
Risk factor aORa 95%  CIb P
Individual risk factors
 Age (by year) 1.06 1.03–1.09 0.001
Household risk factors
 Township
  Amarapura 8.93 1.37–58.32 0.024
  Patheingyi 8.17 0.50–134.56 0.134
  Tada-U 1.56 0.11–21.75 0.755
  Wundwin (ref ) 1.00
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Table 5 Univariate logistic regression analysis of association between never taking MDA medication and individual/household risk 
factors; weighted and adjusted for survey design (n = 1007)
a Adjusted for survey design
b 95% confidence interval
Italics values indicate P < 0.05
Risk factor Total (n) Proportion that had never 
taken MDA medication (%)
Never taken MDA medication
aORa 95%  CIb P-value
Individual risk factors
 Age group (years) 1003
  0–14 177 18.36 1.49 0.74–3.03 0.254
  15–29 201 20.69 1.73 0.93–3.21 0.079
  30–44 (ref ) 273 13.10 1.00
  45–59 221 13.64 1.05 0.53–2.07 0.888
  60+ 131 22.57 1.93 0.89–4.21 0.092
 Gender 1007
  Male 366 21.31 1.61 1.10–2.35 0.017
  Female 641 14.43
 Occupation 986
  None/home duties 263 15.61 0.55 0.20–1.53 0.241
  Student 163 17.29 0.63 0.17–2.36 0.472
  Manual labour 520 16.86 0.61 0.23–1.59 0.296
  Other (ref ) 40 25.04 1.00
 Moved to their current village of residence 1000
  Yes 146 27.96 2.08 1.06–4.07 0.034
  No 854 15.74
 Ever declined MDA medication 935
  Yes 74 52.36 9.18 2.43–34.65 0.002
  No 861 10.70
Household risk factors
 Township 1007
  Amarapura 304 20.22 1.81 1.08–3.03 0.027
  Patheingyi 111 20.29 1.82 0.37–8.80 0.443
  Tada-U 268 20.52 1.84 1.10–3.08 0.022
  Wundwin (ref ) 324 12.30 1.00
 Log household monthly income 970 – 1.52 0.99–2.34 0.055
 Highest level of education 999
  None/primary 326 16.83 1.91 0.76–4.82 0.163
  Secondary 531 19.75 2.32 0.85–6.31 0.095
  Tertiary (ref ) 142 9.59 1.00
 Literacy of household head 994
  Illilterate 84 15.18 0.87 0.34–2.21 0.751
  Partially literate 54 22.64 1.41 0.55–3.67 0.460
  Literate 856 17.15 1.00
 Knowledge of LF (by score, n of 4) 959 – 0.66 0.46–0.94 0.024
 Visited by MDA programme 997
  Yes 939 14.30 0.07 0.03–0.18 < 0.001
  No 58 69.30
 Total number of MDA programme visits (by n of 6) 961 – 0.49 0.33–0.73 0.001
 Proportion of household present during last MDA (ratio) 900 – 0.28 0.06–1.34 0.107
 No. of people per room (ratio) 970 – 1.22 1.04–1.43 0.017
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lower participation could not be accounted for by the 
programmatic reach and compliance factors assessed. 
Of the four townships, Amarapura is the most urban 
and had the highest average household income. Stud-
ies elsewhere have found that MDA participation can be 
more difficult to achieve in urban areas because of a lack 
of urban strategy, fewer peripheral health workers, poor 
health care infrastructure, the presence of unorganised 
settlements and large numbers of migrants [11]. Com-
pared to other townships, Amarapura had the highest 
proportion of individuals who had moved from another 
village but a similar ratio of household members present 
during the last round and the highest number of NPELF 
visits. Within urban areas, studies have also found that 
higher income individuals can be harder to reach in sur-
veys and are more likely to decline to participate in MDA 
programmes [11]. Amarapura had the lowest proportion 
of individuals who reported declining MDA medication. 
When income was assessed in a subgroup analysis of the 
township, however, there was a trend toward lower par-
ticipation with higher income but it did not reach signifi-
cance (cOR = 1.07; p = 0.642; aOR = 1.41; p = 0.080). The 
lower participation levels in Amarapura, therefore, may 
relate to its urban location, more mobile population and 
higher incomes, but this requires further analysis.
In addition to exploring potential causes for persistent 
infection and never taking MDA, this study also assessed 
risk factors for LF-related hydrocoele. The positive asso-
ciation found between age and hydrocoele has been well 
documented [15]. This is thought to be due to the pro-
gressive onset of lymphatic dysfunction with chronic 
filarial infection [38]. Hydrocoele was not found to be 
associated with CFA positivity following adjustment for 
survey design. Men with hydrocoele are often CFA nega-
tive, reflecting the fact that the active infection has often 
ceased by the time hydrocoeles develop. The higher risk 
of hydrocoele in Amarapura probably relates to the his-
torically high infection prevalence there. These findings 
Table 6 Multivariate logistic regression analysis of association between never taking MDA medication and individual/household risk 
factors; weighted and adjusted for survey design (n = 844)
a Adjusted for survey design
b 95% confidence interval
Italics values indicate P < 0.05
Risk factor Without age–gender interaction term With age–gender interaction term
aORa 95% CI P aORb 95% CI P
Individual risk factors
 Age group (years)
  0–14 2.66 1.08–6.62 0.035 4.80 1.40–16.42 0.015
  15–29 1.83 0.91–3.70 0.089 3.78 1.23–11.66 0.023
  30–44 (ref ) 1.00 1.00
  45–59 1.28 0.64–2.55 0.476 3.37 1.0–10.32 0.035
  60+ 4.03 1.53–10.59 0.007 12.82 3.34–49.18 0.001
 Male gender 1.88 1.10–3.23 0.024 6.89 2.13–22.28 0.002
 Age-gender (male) interaction
  0–14 0.38 0.07–2.10 0.253
  15–29 0.29 0.07–1.16 0.078
  30–44 (ref ) 1.00
  45–59 0.17 0.04–0.68 0.015
  60+ 0.10 0.02–0.45 0.004
 Moved to current village of residence 2.57 1.08–6.15 0.035 2.62 1.12–6.11 0.027
 Ever declined MDA medication 10.52 3.86–28.72 < 0.001 11.82 4.25–32.91 < 0.001
Household risk factors
 Township
  Amarapura 2.41 1.14–5.12 0.024 2.48 1.15–5.31 0.022
  Patheingyi 2.07 0.69–6.17 0.183 1.89 0.63–5.68 0.246
  Tada-U 0.55 0.24–1.23 0.136 0.55 0.24–1.26 0.149
  Wundwin (ref ) 1.00 1.00
 Total number of MDA programme visits (by n of 6) 0.67 0.46–0.97 0.033 0.69 0.48–1.00 0.047
 Proportion of household present during last MDA (by ratio) 0.17 0.04–0.80 0.026 0.16 0.03–0.74 0.021
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underscore the importance of reducing infection to pre-
vent the development of LF-related hydrocoele.
The study results reported should be interpreted in 
light of some limitations. First, more females than males 
participated in the study. Whilst gender was adjusted 
for, it led to wider odds ratio confidence intervals. Sec-
ond, data were missing from a number of risk factor 
variables (see total column in Tables 1, 3 and 5) leading 
to fewer numbers of participants in the final models for 
infection and never taking MDA. In addition to widening 
confidence intervals, it is possible this may have biased 
the results. Third, other potential environmental factors 
such as rainfall, temperature and population density were 
not included, which may have provided a more com-
plete explanation of risk. Lastly, local health workers and 
members of the NPELF assisted with data collection. It 
is therefore possible that participants’ responses regard-
ing MDA participation could have been biased towards 
‘acceptable’ replies. The low levels of reported MDA par-
ticipation, however, suggest this was unlikely.
The results of this study will assist Myanmar’s NPELF 
and contribute to the global understanding of LF risk fac-
tors. Knowledge of the factors associated with persistent 
infection and never taking MDA will help the National 
Programme to better allocate its resources in elimina-
tion efforts. Maximising MDA participation is critical as 
Myanmar transitions from the two-drug to three-drug 
MDA (ivermectin, diethylcarbamazine and albendazole, 
IDA) starting in 2020, since models predict that fewer 
rounds of IDA are needed to stop transmission [39]. 
To do this, our results suggest that emphasis should be 
placed on both improving reach, with particular atten-
tion to mopping-up missed participants, and compliance 
through educational initiatives. Since the findings reflect 
many common global reasons for poor MDA uptake 
and those of Linn et al., it is reasonable to infer that they 
could be generalisable to other regions of Myanmar. The 
identified infection risk factors may also apply to other 
countries where Culex is the vector. Finally, the iden-
tification of hydrocoele risk factors contributes to the 
understanding of LF morbidity and will help Myanmar to 
better target alleviation programmes.
Conclusions
This population-representative study assessed risk fac-
tors for LF infection, disease and never taking MDA in an 
area of persistent LF transmission in Myanmar. It found 
that persistent LF infection was linked to both individual 
and household factors. In turn, never taking MDA was 
related to both programme reach and individual com-
pliance factors. It also highlighted that hydrocoele risk 
was higher in those who were older and residing in the 
historically high prevalence township of Amarapura. 
These results will assist the NPELF to improve its MDA 
rounds and to better target its morbidity management 
programmes.
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